Do you want to read an article? Please log in or register.
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2024
Further Publications
Related content
Hepatology
Prevalence of metabolic dysfunction-associated steatotic liver disease and fibrosis defined by liver elastography in the United States using National Health and Nutrition examination survey 2017-march 2020 and august 2021-august 2023 data
Hepatology
Unalp-Arida A, Ruhl CE
doi: 10.1097/HEP.0000000000001211
Hepatology
Validation and epidemiologic definition of the novel steatotic liver disease nomenclature in a national United States cohort with cirrhosis
Clin Gastroenterol Hepatol
Mezzacappa C, Ochoa-Allemant P, Serper M, Taddei TH, John BV, Kaplan DE, Mahmud N
doi: 10.1016/j.cgh.2024.10.035
Hepatology
Epidemiology of compensated Advanced Chronic Liver Disease (cACLD) in the United States: Insights from NHANES 2017-2020
Clin Gastroenterol Hepatol
Goyal RM, Doshi A, Rao S, Arora K, Maheshwari S, Gaglio P
doi: 10.1016/j.cgh.2025.06.010
Hepatitis
Estimation of the Eligible Population For Resmetirom Among Adults in the United States for Treatment of Non-Cirrhotic NASH with Moderate-to-Advanced Liver Fibrosis
Adv Ther
Fishman J, Kim Y, Charlton MR, Smith ZJ, O'Connell T, Bercaw EM
doi: 10.1007/s12325-024-02989-5
RECOMMENDED
Gastrointestinal CancerInflammatory Bowel Disease
Risk of Small Intestine Cancer in Inflammatory Bowel Disease: A Propensity-Matched Study from a Large Multi-Center Database in the United States
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Am J Gastroenterol
Alsakarneh S, Ahmed M, Azim S, Hashash JG, Farraye FA, Ghoz H
doi: 10.14309/ajg.0000000000002984
Hepatology
Association of Food Insecurity with the Prevalence and Liver-related Mortality of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
J Hepatol
Younossi ZM, Zelber-Sagi S, Kuglemas C, Lazarus JV, Paik A, de Avila L, Gerber L, Paik JM
doi: 10.1016/j.jhep.2024.08.011
Hepatology
Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study : MASLD, MetALD, and dementia risk
BMC Gastroenterol
Shin WY, Kang ES, Oh YH, Sha M, Xia Q, Jeong S, Cho Y
doi: 10.1186/s12876-025-03814-1
Hepatology
Metabolic Cause of Cirrhosis Is the Emerging Etiology for Primary Liver Cancer in the Asia-Oceania Region: Analysis of Global Burden of Disease (GBD) Study 2021
J Gastroenterol Hepatol
Giri S, Ingawale S, Khatana G, Gore P, Praharaj DL, Wong VW, Huang DQ, Singhal A, Choudhury A
doi: 10.1111/jgh.16922
Hepatology
Non-invasive assessment of severe liver fibrosis in patients with Fontan-associated liver disease: The VALDIG-EASL FONLIVER cohort
J Hepatol
Téllez L, Rincón D, Payancé A, Jaillais A, Lebray P, Rodríguez de Santiago E, Clemente A, Paradis V, Lefort B, Garrido-Lestache E, Prieto R, Iserin L, Tallegas M, Garrido E, Torres M, Muriel A, Perna C, Jesús Del Cerro M, d'Alteroche L, Rautou PE, Bañares R, Albillos A, VALDIG-EASL consortium
doi: 10.1016/j.jhep.2024.09.005